MedCity and the KPBMA on the Evolution of Immuno-Oncology

MedCity, and the Advanced Therapies Network are partnering with the KPBMA (Korean Pharmaceutical and BioPharma Manufacturers Association) to host a joint virtual breakfast webinar on  New Approaches to Immuno-Oncology- Trends and Evolution in Advanced Therapies.

High profile speakers from the UK and Korea will be sharing their insights during this international collaborative event.

This 1 hour 30-minute International virtual scientific showcase and Q&A will feature presentations from members of the advanced therapies network as well as expertise from Korea where partners KPBMA (Korea Pharmaceutical and Bio-Pharma Manufacturers Association).

Agenda: 

Opening and Introduction:

Dr Francesca Gliubich- Director London Advanced Therapies, King’s College London

Phil Jackson- Head of International, MedCity

Kevin Huh, Vice Chairman, KPBMA

Speakers and Presenters:

Professor Farzin Farzaneh- Professor of Molecular Medicine, King’s College London – Cells, genes and peptides for active immune therapy of cancer

Professor Howard Lee– Professor of Clinical Pharmacology and Therapeutics,  Seoul National University Hospital  & Professor of Molecular Medicine & Biopharmaceutical Sciences, Seoul National University- Current Status of Advanced Therapeutics Development in Korea

Professor Francesca Ciccarelli  Professor of Cancer Genomics, Kings College, London and Group Leader, The Francis Crick Institute- Immunogenics of Colorectal Cancer Response to Immune Checkpoint Blockade

Professor Jong Seong Ahn – Executive Director of GC Cell Research Centre, Seoul – Development of Immune Cell Therapies for Solid Tumour

This event is open to all those working in advanced therapies. To find out more about joining the advanced therapies network please contact us or go to https://www.medcityhq.com/advanced-therapies-network/